BioScience Health Innovations, Inc. financial data

Symbol
BHIC on OTC
Location
Salt Lake City, UT
Fiscal year end
31 December
Latest financial report
10-Q - Q3 2025 - 27 Oct 2025

Key Ratios

Label TTM Value / Value Unit Change %
Debt-to-equity 16% % -50%
Return On Equity 64% % 177%
Return On Assets 55% % 214%
Operating Margin 19% % 646%

Shares

Label TTM Value / Value Unit Change %
Entity Common Stock, Shares Outstanding 10,979,055 shares -74%
Common Stock, Shares, Outstanding 10,979,055 shares -74%
Entity Public Float $41,596,221 USD
Common Stock, Value, Issued $1,098 USD -74%
Weighted Average Number of Shares Outstanding, Basic 10,979,055 shares 4.8%
Weighted Average Number of Shares Outstanding, Diluted 10,979,055 shares 0.78%

Income Statement

Label TTM Value / Value Unit Change %
Revenues $4,726,182 USD 207%
Research and Development Expense $37,540 USD 4563%
Operating Income (Loss) $885,677 USD 2191%
Income Tax Expense (Benefit) $0 USD
Net Income (Loss) Attributable to Parent $885,677 USD 2191%
Earnings Per Share, Basic 0 USD/shares -100%
Earnings Per Share, Diluted 0 USD/shares -100%

Balance Sheet

Label TTM Value / Value Unit Change %
Cash and Cash Equivalents, at Carrying Value $1,139,423 USD 242%
Accounts Receivable, after Allowance for Credit Loss, Current $63,212 USD 98%
Inventory, Net $757,500 USD 1694%
Assets, Current $1,994,999 USD 388%
Intangible Assets, Net (Excluding Goodwill) $72,101 USD 925%
Assets $2,067,100 USD 397%
Accounts Payable, Current $10,165 USD 20%
Accrued Liabilities, Current $6,686 USD 167%
Liabilities $356,140 USD 682%
Retained Earnings (Accumulated Deficit) $534,637 USD
Stockholders' Equity Attributable to Parent $1,710,960 USD 362%
Liabilities and Equity $2,067,100 USD 397%

Popular Metrics

Label TTM Value / Value Unit Change %
Net Cash Provided by (Used in) Operating Activities $328,309 USD
Net Cash Provided by (Used in) Financing Activities $67,516 USD -45%
Net Cash Provided by (Used in) Investing Activities $30,000 USD
Common Stock, Shares Authorized 250,000,000 shares 233%
Common Stock, Shares, Issued 10,979,055 shares -74%
Common Stock, Par or Stated Value Per Share 0 USD/shares 0%
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents $1,139,423 USD 242%
Interest Paid, Excluding Capitalized Interest, Operating Activities $0 USD
Deferred Tax Assets, Valuation Allowance $48,977 USD -33%
Deferred Tax Assets, Operating Loss Carryforwards $47,419 USD -5.4%
Preferred Stock, Shares Issued 140,000 shares 0%
Preferred Stock, Shares Authorized 140,000 shares 0%
Additional Paid in Capital $1,175,211 USD 64%
Preferred Stock, Shares Outstanding 140,000 shares 0%
Deferred Tax Assets, Net of Valuation Allowance $0 USD
Preferred Stock, Par or Stated Value Per Share 0 USD/shares 0%